AbbVie Inc. is a global, diversified, research-based biopharmaceutical company. It is engaged in research and development, manufacturing, commercialization and sale of medicines and therapies. Its product portfolio includes Immunology, Oncology, Aesthetics, Neuroscience, Eye Care and Other Key Products. Immunology products include rheumatology, dermatology and gastroenterology. Oncology products include Imbruvica, Venclexta/Venclyxto, Elahere and Epkinly. The aesthetics portfolio consists of facial injectables, plastics and regenerative medicine, body contouring, and skincare products. Its Neuroscience products include Botox Therapeutic, Vraylar, Duopa and Duodopa, Ubrelvy, and Qulipta. Duodopa is a levodopa-carbidopa intestinal gel for the treatment of Parkinson's disease. Eye care products include Ozurdex, Lumigan/Ganfort, Alphagan/Combigan, and Restasis. Other key products include Mavyret/Maviret, Creon, and Linzess/Constella. Its pipeline also includes zumilokibart and APG273.
Back to dashboard
Company Information
About this company
Key people
Robert A. Michael
Chairman of the Board, Chief Executive Officer
Roxanne S. Austin
Lead Independent Director
William H. L. Burnside
Independent Director
John M. Carethers
Independent Director
Jennifer L. Davis
Independent Director
Thomas J. Falk
Independent Director
Scott T. Reents
Chief Financial Officer, Executive Vice President
Azita Saleki-Gerhardt
Executive Vice President, Chief Operations Officer
Demetris D. Crum
Chief Human Resources Officer, Executive Vice President
Roopal Thakkar
Executive Vice President - Research & Development, Chief Scientific Officer
Perry C. Siatis
Executive Vice President, General Counsel, Secretary
Nicholas J. Donoghoe
Executive Vice President, Chief Business and Strategy Officer
Jeffrey R. Stewart
Executive Vice President, Chief Commercial Officer
David R. Purdue
Senior Vice President, Controller
Click to see more
Key facts
- Shares in issue1.84bn
- EPICABBV
- ISINUS00287Y1091
- LocationUnited States
- SectorHealthcare
- IndustryBiotechnology & Drugs
- Market cap$504.37bn
- Employees57,000
- ExchangeNew York Stock Exchange
- IndexS&P 500, TR Equity United States Index
- Website
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.